{"DataElement":{"publicId":"14688604","version":"1","preferredName":"Specimen Neoplasm Category","preferredDefinition":"A text term based on categorization of cytologic atypia found in cellular molecules, cells, tissues, organs, body fluids, or body excretory products.","longName":"14685927v1.00:14685928v1.00","context":"CRDC","contextVersion":"1","DataElementConcept":{"publicId":"14685927","version":"1","preferredName":"Specimen Neoplasm","preferredDefinition":"Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products.:A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","longName":"2859635v1.00:2431212v1.00","context":"CRDC","contextVersion":"1","ObjectClass":{"publicId":"2859635","version":"1","preferredName":"Biospecimen","preferredDefinition":"Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products.","longName":"C70699","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Biospecimen","conceptCode":"C70699","definition":"Any material sample taken from a biological entity for testing, diagnostic, propagation, treatment or research purposes, including a sample obtained from a living organism or taken from the biological object after halting of all its life functions. Biospecimen can contain one or more components including but not limited to cellular molecules, cells, tissues, organs, body fluids, embryos, and body excretory products.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66832E51-39F3-1736-E040-BB89AD4349FB","latestVersionIndicator":"Yes","beginDate":"2009-04-01","endDate":null,"createdBy":"UMLLOADER_TAVERNA","dateCreated":"2009-04-01","modifiedBy":"ONEDATA","dateModified":"2009-04-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2431212","version":"1","preferredName":"Neoplasm","preferredDefinition":"An abnormal tissue growth resulted from uncontrolled cell proliferation.  Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant ones exhibit overt signs such as dysplastic features, atypical mitotic","longName":"C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05DCE203-C860-3264-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-18","endDate":null,"createdBy":"UMLLOADER_CAP","dateCreated":"2005-11-18","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435018","version":"1","preferredName":"Clinical or Research Activity","preferredDefinition":"Any specific activity undertaken during the course of a clinical study or research protocol.","longName":"C16203","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-831E-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CRDC:Cancer Research Data Commons","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0F3A5F44-C194-4E0A-E063-731AD00ADCD2","latestVersionIndicator":"Yes","beginDate":"2024-01-18","endDate":null,"createdBy":"COLBERTM","dateCreated":"2024-01-18","modifiedBy":"COLBERTM","dateModified":"2024-01-31","changeDescription":null,"administrativeNotes":"1/31/24 Released as part of CRDC standard CDE per DSS mtg 1/31/24. mr; \r\n1/18/24 Created per CRDC DSS. mr","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"14685928","version":"1","preferredName":"Neoplasm Category","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias._A grouping of items based on some commonality or by user defined characteristics.","longName":"14685928v1.00","context":"CRDC","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Peritumoral","valueDescription":null,"ValueMeaning":{"publicId":"13332906","version":"1","preferredName":"Tumor-Adjacent Normal Specimen","longName":"13332906v1.00","preferredDefinition":"A specimen comprised of morphologically normal tissue collected from the area immediately surrounding a tumor in an experimental subject.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor-Adjacent Normal Specimen","conceptCode":"C164032","definition":"A specimen comprised of morphologically normal tissue collected from the area immediately surrounding a tumor in an experimental subject.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F8C5D846-95CF-327B-E053-731AD00AACD2","latestVersionIndicator":"Yes","beginDate":"2023-04-07","endDate":null,"createdBy":"FINCHAMB","dateCreated":"2023-04-07","modifiedBy":"FINCHAMB","dateModified":"2023-04-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3C2AD2-06CF-36D2-E063-731AD00AD2BB","beginDate":"2024-01-18","endDate":null,"createdBy":"COLBERTM","dateCreated":"2024-01-18","modifiedBy":"COLBERTM","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"Not Reported","valueDescription":null,"ValueMeaning":{"publicId":"5612322","version":"1","preferredName":"Not Reported","longName":"5612322v1.00","preferredDefinition":"Not provided or available.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Reported","conceptCode":"C43234","definition":"Not provided or available.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"45340835-3B00-7C78-E053-F662850A44F9","latestVersionIndicator":"Yes","beginDate":"2017-01-03","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-01-03","modifiedBy":"FINCHAMB","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"10/10/23 changed Long Name from \"Not Stated\" to match NCIt Preferred name and current caDSR concept Long Name of \"Not Reported\" per Brenda.Janice . LS","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0F3C2C6F-3671-3765-E063-731AD00A031E","beginDate":"2024-01-18","endDate":null,"createdBy":"COLBERTM","dateCreated":"2024-01-18","modifiedBy":"COLBERTM","dateModified":"2024-01-18","deletedIndicator":"No"},{"value":"Tumor","valueDescription":null,"ValueMeaning":{"publicId":"3184945","version":"1","preferredName":"Tumor Tissue","longName":"3184945","preferredDefinition":"A tissue sample, or entire tumor that is removed for microscopic examination.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Tissue Sample","conceptCode":"C18009","definition":"Tissue sample that contains an abnormal cellular infiltrate forming a solid mass. The abnormal cellular component can be benign or malignant. Tumor samples are obtained for microscopic examination and/or molecular analysis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9A40CFA4-3AF7-0443-E040-BB89AD434182","latestVersionIndicator":"Yes","beginDate":"2011-01-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-01-19","modifiedBy":"COLBERTM","dateModified":"2024-02-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"104495AF-0B9E-6363-E063-731AD00A0673","beginDate":"2024-01-31","endDate":null,"createdBy":"COLBERTM","dateCreated":"2024-01-31","modifiedBy":"COLBERTM","dateModified":"2024-01-31","deletedIndicator":"No"},{"value":"Normal","valueDescription":null,"ValueMeaning":{"publicId":"14741231","version":"1","preferredName":"Normal Tissue Sample","longName":"14741231v1.00","preferredDefinition":"Tissue sample with cellular composition and architectural patterns expected for the particular anatomic site in which it belongs. There is no evidence of abnormal cellular infiltrates or tumor mass formation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Normal Tissue Sample","conceptCode":"C162623","definition":"Tissue sample with cellular composition and architectural patterns expected for the particular anatomic site in which it belongs. There is no evidence of abnormal cellular infiltrates or tumor mass formation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"104495AF-0B9D-6363-E063-731AD00A0673","latestVersionIndicator":"Yes","beginDate":"2024-01-31","endDate":null,"createdBy":"COLBERTM","dateCreated":"2024-01-31","modifiedBy":"COLBERTM","dateModified":"2024-01-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"104495AF-0B9F-6363-E063-731AD00A0673","beginDate":"2024-01-31","endDate":null,"createdBy":"COLBERTM","dateCreated":"2024-01-31","modifiedBy":"COLBERTM","dateModified":"2024-01-31","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435018","version":"1","preferredName":"Clinical or Research Activity","preferredDefinition":"Any specific activity undertaken during the course of a clinical study or research protocol.","longName":"C16203","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741AE5B-831E-25C7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6404684","version":"1","preferredName":"Neoplasm Category","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.:A grouping of items based on some commonality or by user defined characteristics.","longName":"C3262:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"73E222FE-8F9B-0A1F-E053-F662850A42C6","latestVersionIndicator":"Yes","beginDate":"2018-08-20","endDate":null,"createdBy":"SOKKERL","dateCreated":"2018-08-20","modifiedBy":"ONEDATA","dateModified":"2018-08-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CRDC:Cancer Research Data Commons","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"0F3A69BC-4B9A-4FCF-E063-731AD00A1EA3","latestVersionIndicator":"Yes","beginDate":"2024-01-18","endDate":null,"createdBy":"COLBERTM","dateCreated":"2024-01-18","modifiedBy":"COLBERTM","dateModified":"2024-01-31","changeDescription":null,"administrativeNotes":"1/31/24 Added Tumor and Normal PVs. Released as CRDC standard per CRDC DSS mtg 1/31/24. mr; \r\n1/18/24 Created per CRDC DSS. mr","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"10466051","version":"1","longName":"All CRDC Standard Data Elements","context":"CRDC","ClassificationSchemeItems":[{"publicId":"10466053","version":"1","longName":"Specimen","context":"CRDC"}]},{"publicId":"11518160","version":"1","longName":"CTDC (Clinical Trial Data Commons)","context":"CRDC","ClassificationSchemeItems":[{"publicId":"14413707","version":"1","longName":"CTDC Model","context":"CRDC"},{"publicId":"14413713","version":"1","longName":"Biospecimen","context":"CRDC"}]},{"publicId":"8064110","version":"1","longName":"CDS (Cancer Data Service)","context":"CRDC","ClassificationSchemeItems":[{"publicId":"14470388","version":"1","longName":"Imaging","context":"CRDC"}]}],"AlternateNames":[{"name":"Specimen Tumor or Normal Category","type":"CRDC Alt Name","context":"CRDC"},{"name":"type_of_tissue","type":"CTDC Alt Name","context":"CRDC"},{"name":"tissue_category","type":"CTDC Alt Name","context":"CRDC"},{"name":"sample_tumor_status","type":"CDS Alt Name","context":"CRDC"}],"ReferenceDocuments":[{"name":"PQT","type":"Preferred Question Text","description":"Specimen Category","url":null,"context":"CRDC"}],"origin":"CRDC:Cancer Research Data Commons","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"0F3A7E37-7FC9-5360-E063-731AD00A7033","latestVersionIndicator":"Yes","beginDate":"2024-01-18","endDate":null,"createdBy":"COLBERTM","dateCreated":"2024-01-18","modifiedBy":"FINCHAMB","dateModified":"2024-02-06","changeDescription":null,"administrativeNotes":"2/6/24 Added CDS Alt name, def and CSI. BF1/31/24 Released as CRDC Standard per DSS mtg 1/31/24. mr; \r\n1/18/24 Created per CRDC DSS. mr","unresolvedIssues":null,"deletedIndicator":"No"}}